istock-92036866

26 October 2018Americas

Interpol seizes 500 tonnes of illicit pharmaceuticals

More than 500 tonnes of illicit pharmaceuticals have been seized worldwide as part of a global operation led by Interpol, as announced on Tuesday.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Counterfeiters exploiting COVID-19 outbreak: MHRA

24 March 2020 Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

article

MHRA seizes fake medicine worth more than £2m

31 October 2018 The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.

More on this story

Counterfeiters exploiting COVID-19 outbreak: MHRA

24 March 2020 Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

article

MHRA seizes fake medicine worth more than £2m

31 October 2018 The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.

More on this story

Counterfeiters exploiting COVID-19 outbreak: MHRA

24 March 2020 Counterfeit face masks and unauthorised antiviral medication have been seized under Interpol’s annual Operation Pangea, as criminals seek to take advantage of the COVID-19 pandemic by exploiting demand.

article

MHRA seizes fake medicine worth more than £2m

31 October 2018 The Medicines and Healthcare Products Regulatory Agency has seized more than £2 million ($2.6 million) worth of counterfeit medication in the UK, according to the a statement made by the UK government.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?